SCHEMBL22745997

SCHEMBL22745997

O=C1NC(=O)C2(CCCCC2)c2cc(Br)ccc21

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP2 O95551 3/20 0.47
▸ AKR1A1 P14550 1/20 0.40
▸ AKR1B1 P15121 1/20 0.40
▸ PGR P06401 4/20 0.38
▸ PARP10 Q53GL7 2/20 0.37
▸ PARP11 Q9NR21 1/20 0.37
▸ PARP1 P09874 1/20 0.37
▸ LRRK2 Q5S007 1/20 0.37
▸ TGM2 P21980 1/20 0.37
▸ CES1 P23141 1/20 0.37
▸ PDE4A P27815 1/20 0.36
▸ PDE4B Q07343 1/20 0.36
▸ PDE4C Q08493 1/20 0.36
▸ PDE4D Q08499 1/20 0.36
▸ PDE3B Q13370 1/20 0.36
▸ PDE3A Q14432 1/20 0.36
▸ MAOA P21397 2/20 0.36
▸ MAOB P27338 2/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24895273 0.98 TDP2 (0.49) TDP2AKR1A1AKR1B1PGRPARP10
SCHEMBL22745965 0.95 TDP2 (0.49) TDP2AKR1A1AKR1B1PGRPARP10
SCHEMBL24894969 0.92 TDP2 (0.51) TDP2AKR1A1AKR1B1PARP10PARP11
SCHEMBL24895037 0.81 TDP2 (0.47) TDP2AKR1A1AKR1B1PARP10PARP11
SCHEMBL61843 0.81 PGR (0.56) PGRPDE4APDE4BPDE4CPDE4D
SCHEMBL24895277 0.80 TDP2 (0.46) TDP2AKR1A1AKR1B1PARP10PARP11
SCHEMBL13337301 0.79 KCNK2 (0.42) TDP2AKR1A1AKR1B1ALDH1A1
SCHEMBL12306672 0.79 KCNK2 (0.42) TDP2AKR1A1AKR1B1ALDH1A1
SCHEMBL22904499 0.79 TDP2 (0.47) TDP2AKR1A1AKR1B1PARP10PARP11
SCHEMBL1223242 0.79 PGR (0.55) PGRPDE4APDE4BPDE4CPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020240493-A1 1,3,4-OXADIAZOLE HOMOPHTHALIMIDE DERIVATIVE COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR, AND THE PHARMACEUTICAL COMPOSITION COMPRISING THE SAME CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2020-12-03 — — WO disclosed
Send feedback